ID

16770

Description

Study of Nitazoxanide Combined With Peginterferon Compared to Peginterferon Monotherapy in the Treatment of Hepatitis C; ODM derived from: https://clinicaltrials.gov/show/NCT00418054

Link

https://clinicaltrials.gov/show/NCT00418054

Keywords

Versions (1)
  1. 8/5/16 8/5/16 -
Uploaded on

August 5, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Chronic Hepatitis C NCT00418054

English

Eligibility Chronic Hepatitis C NCT00418054

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
age ≥18 years.
Description

age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
chronic hepatitis c infection (at least 6 months) evidenced by a positive enzyme immunoassay for anti-hcv-antibodies and a positive quantitative rt-pcr amplification of hcv rna.
Description

chronic hepatitis c infection evidenced by a positive enzyme immunoassay for anti-hcv-antibodies and a positive quantitative rt-pcr amplification of hcv rna.

Data type

boolean

Alias
UMLS CUI [1]
C0524910
UMLS CUI [2]
C0086231
UMLS CUI [3]
C0166049
UMLS CUI [4]
C0369335
chronic inflammation on liver biopsy compatible with a diagnosis of chronic viral hepatitis.
Description

liver biopsy, chronic viral hepatitis

Data type

boolean

Alias
UMLS CUI [1]
C0193388
UMLS CUI [2]
C0011900
UMLS CUI [3]
C0276623
hcv genotype 4.
Description

hcv genotype 4

Data type

boolean

Alias
UMLS CUI [1]
C1148363
patients that have not previously received peginterferon.
Description

peginterferon

Data type

boolean

Alias
UMLS CUI [1]
C0982327
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients unable to take oral medications.
Description

patients unable to take oral medications

Data type

boolean

Alias
UMLS CUI [1,1]
C0175795
UMLS CUI [1,2]
C3494765
use of ribavirin within 30 days prior to enrollment.
Description

ribavirin

Data type

boolean

Alias
UMLS CUI [1]
C0035525
females who are either pregnant, breast-feeding or not using birth control and are sexually active.
Description

pregnant or breastfeeding, contraception, sexually active

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C0700589
UMLS CUI [4]
C0241028
any investigational drug therapy within 30 days prior to enrollment other than through romark study number rm01-3027.
Description

investigational drug therapy

Data type

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C0162778
patients with other causes of liver disease.
Description

liver disease

Data type

boolean

Alias
UMLS CUI [1,1]
C0023895
UMLS CUI [1,2]
C0015127
transplant recipients receiving immune suppression therapy.
Description

transplant recipients receiving immune suppression therapy.

Data type

boolean

Alias
UMLS CUI [1]
C0376387
UMLS CUI [2]
C0021079
patient co-infected with human immunodeficiency virus, hepatitis a virus, hepatitis b virus, or hepatitis d virus based on enzyme immunoassay.
Description

patient co-infected with human immunodeficiency virus, hepatitis a virus, hepatitis b virus, or hepatitis d virus

Data type

boolean

Alias
UMLS CUI [1]
C0275524
UMLS CUI [2]
C0019682
UMLS CUI [3]
C0019163
UMLS CUI [4]
C0376325
UMLS CUI [5]
C0011226
patients with decompensated cirrhosis, thrombocytopenia (platelet count <80,000), neutropenia, history of variceal bleeding, ascites, hepatic encephalopathy or ctp scores >6.
Description

decompensated cirrhosis, thrombocytopenia (platelet count <80,000), neutropenia, history of variceal bleeding, ascites, hepatic encephalopathy or ctp scores >6.

Data type

boolean

Alias
UMLS CUI [1]
C1619727
UMLS CUI [2]
C0040034
UMLS CUI [3]
C0027947
UMLS CUI [4]
C0003962
UMLS CUI [5]
C0019151
patients with history of alcoholism (unless abstinent for 2 years) or with an alcohol consumption of >20 grams per day.
Description

alcohol consumption

Data type

boolean

Alias
UMLS CUI [1]
C0001948
patients who are clinically unstable.
Description

clinically unstable

Data type

boolean

Alias
UMLS CUI [1]
C0443343
patients with any concomitant condition that, in the opinion of the investigator would preclude evaluation of response or make it unlikely that the contemplated course of therapy and follow-up could be completed.
Description

comorbidity

Data type

boolean

Alias
UMLS CUI [1]
C0009488
history of hypersensitivity or intolerance to any of the excipients comprising the nitazoxanide tablets or peginterferon alfa-2b solution for injection.
Description

hypersensitivity to nitazoxanide or peg interferon alfa-2b

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0068788
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0796545
Back to the top of the page

Similar models

Eligibility Chronic Hepatitis C NCT00418054

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
age
Item
age ≥18 years.
boolean
C0001779 (UMLS CUI [1])
chronic hepatitis c infection evidenced by a positive enzyme immunoassay for anti-hcv-antibodies and a positive quantitative rt-pcr amplification of hcv rna.
Item
chronic hepatitis c infection (at least 6 months) evidenced by a positive enzyme immunoassay for anti-hcv-antibodies and a positive quantitative rt-pcr amplification of hcv rna.
boolean
C0524910 (UMLS CUI [1])
C0086231 (UMLS CUI [2])
C0166049 (UMLS CUI [3])
C0369335 (UMLS CUI [4])
liver biopsy, chronic viral hepatitis
Item
chronic inflammation on liver biopsy compatible with a diagnosis of chronic viral hepatitis.
boolean
C0193388 (UMLS CUI [1])
C0011900 (UMLS CUI [2])
C0276623 (UMLS CUI [3])
hcv genotype 4
Item
hcv genotype 4.
boolean
C1148363 (UMLS CUI [1])
peginterferon
Item
patients that have not previously received peginterferon.
boolean
C0982327 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
patients unable to take oral medications
Item
patients unable to take oral medications.
boolean
C0175795 (UMLS CUI [1,1])
C3494765 (UMLS CUI [1,2])
ribavirin
Item
use of ribavirin within 30 days prior to enrollment.
boolean
C0035525 (UMLS CUI [1])
pregnant or breastfeeding, contraception, sexually active
Item
females who are either pregnant, breast-feeding or not using birth control and are sexually active.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0700589 (UMLS CUI [3])
C0241028 (UMLS CUI [4])
investigational drug therapy
Item
any investigational drug therapy within 30 days prior to enrollment other than through romark study number rm01-3027.
boolean
C2348568 (UMLS CUI [1,1])
C0162778 (UMLS CUI [1,2])
liver disease
Item
patients with other causes of liver disease.
boolean
C0023895 (UMLS CUI [1,1])
C0015127 (UMLS CUI [1,2])
transplant recipients receiving immune suppression therapy.
Item
transplant recipients receiving immune suppression therapy.
boolean
C0376387 (UMLS CUI [1])
C0021079 (UMLS CUI [2])
patient co-infected with human immunodeficiency virus, hepatitis a virus, hepatitis b virus, or hepatitis d virus
Item
patient co-infected with human immunodeficiency virus, hepatitis a virus, hepatitis b virus, or hepatitis d virus based on enzyme immunoassay.
boolean
C0275524 (UMLS CUI [1])
C0019682 (UMLS CUI [2])
C0019163 (UMLS CUI [3])
C0376325 (UMLS CUI [4])
C0011226 (UMLS CUI [5])
decompensated cirrhosis, thrombocytopenia (platelet count <80,000), neutropenia, history of variceal bleeding, ascites, hepatic encephalopathy or ctp scores >6.
Item
patients with decompensated cirrhosis, thrombocytopenia (platelet count <80,000), neutropenia, history of variceal bleeding, ascites, hepatic encephalopathy or ctp scores >6.
boolean
C1619727 (UMLS CUI [1])
C0040034 (UMLS CUI [2])
C0027947 (UMLS CUI [3])
C0003962 (UMLS CUI [4])
C0019151 (UMLS CUI [5])
alcohol consumption
Item
patients with history of alcoholism (unless abstinent for 2 years) or with an alcohol consumption of >20 grams per day.
boolean
C0001948 (UMLS CUI [1])
clinically unstable
Item
patients who are clinically unstable.
boolean
C0443343 (UMLS CUI [1])
comorbidity
Item
patients with any concomitant condition that, in the opinion of the investigator would preclude evaluation of response or make it unlikely that the contemplated course of therapy and follow-up could be completed.
boolean
C0009488 (UMLS CUI [1])
hypersensitivity to nitazoxanide or peg interferon alfa-2b
Item
history of hypersensitivity or intolerance to any of the excipients comprising the nitazoxanide tablets or peginterferon alfa-2b solution for injection.
boolean
C0020517 (UMLS CUI [1,1])
C0068788 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0796545 (UMLS CUI [2,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial